Loading...

Jeanna L Welborn

Title(s)Professor, Hematology and Oncology
SchoolUniversity of California, Davis
Phone916-734-3772
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Tomlinson BK, Tuscano JM, Abedi M, Welborn J, Arora M, O'Donnell RT, Wun T, Jonas BA. A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia. Am J Hematol. 2019 Nov; 94(11):E291-E294. PMID: 31379016.
      View in: PubMed
    2. Su RJ, Jonas BA, Welborn J, Gregg JP, Chen M. Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Hum Pathol (N Y). 2016 Sep; 5:6-9. PMID: 27458550.
      View in: PubMed
    3. Tuscano JM, Dutia M, Chee K, Brunson A, Reed-Pease C, Abedi M, Welborn J, O'Donnell RT. Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma. Br J Haematol. 2014 May; 165(3):375-81. PMID: 24606326.
      View in: PubMed
    4. Welborn J, Fenner S, Parks R. Angioleiomyoma: a benign tumor with karyotypic aberrations. Cancer Genet Cytogenet. 2010 Jun; 199(2):147-8. PMID: 20471520.
      View in: PubMed
    5. Welborn J, Fenner S, Parks R. Features of polycythemia vera in the 8p12 myeloproliferative syndrome. Cancer Genet Cytogenet. 2010 May; 199(1):53-5. PMID: 20417870.
      View in: PubMed
    6. Welborn J. Review: erythropoietin or darbepoetin for anemia in patients with cancer produces both benefits and harms with no increase in survival. ACP J Club. 2007 Jan-Feb; 146(1):6. PMID: 17203926.
      View in: PubMed
    7. Lakshminarayanan R, Konia T, Welborn J. Fibrous hamartoma of infancy: a case report with associated cytogenetic findings. Arch Pathol Lab Med. 2005 Apr; 129(4):520-2. PMID: 15794678.
      View in: PubMed
    8. Welborn J. Review: oral and intravenous antibiotics do not differ for effectiveness in febrile neutropenic patients with cancer. ACP J Club. 2005 Mar-Apr; 142(2):32. PMID: 15739979.
      View in: PubMed
    9. Welborn J, Jenks H, Taplett J, Walling P. High-grade neuroendocrine carcinomas display unique cytogenetic aberrations. Cancer Genet Cytogenet. 2004 Nov; 155(1):33-41. PMID: 15527900.
      View in: PubMed
    10. Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, Wun T, Gandara DR, Lara PN. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004 Sep-Oct; 10(5):294-300. PMID: 15530258.
      View in: PubMed
    11. Welborn J. Acquired Robertsonian translocations are not rare events in acute leukemia and lymphoma. Cancer Genet Cytogenet. 2004 May; 151(1):14-35. PMID: 15120908.
      View in: PubMed
    12. Rodler E, Welborn J, Hatcher S, Unger K, Larkin E, Gumerlock PH, Wun T, Richman C. Blastic mantle cell lymphoma developing concurrently in a patient with chronic myelogenous leukemia and a review of the literature. Am J Hematol. 2004 Apr; 75(4):231-8. PMID: 15054816.
      View in: PubMed
    13. Welborn J. Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies. Cancer Genet Cytogenet. 2004 Mar; 149(2):137-53. PMID: 15036890.
      View in: PubMed
    14. Welborn J, Jenks H, Taplett J, Walling P. Inversion of chromosome 12 and lineage promiscuity in hematologic malignancies. Cancer Genet Cytogenet. 2004 Jan 15; 148(2):91-103. PMID: 14734219.
      View in: PubMed
    15. Lara PN, Higdon R, Lim N, Kwan K, Tanaka M, Lau DH, Wun T, Welborn J, Meyers FJ, Christensen S, O'Donnell R, Richman C, Scudder SA, Tuscano J, Gandara DR, Lam KS. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001 Mar 15; 19(6):1728-33. PMID: 11251003.
      View in: PubMed
    16. Wun T, Paglieroni T, Field CL, Welborn J, Cheung A, Walker NJ, Tablin F. Platelet-erythrocyte adhesion in sickle cell disease. J Investig Med. 1999 Mar; 47(3):121-7. PMID: 10198567.
      View in: PubMed
    17. Wun T, Paglieroni T, Rangaswami A, Franklin PH, Welborn J, Cheung A, Tablin F. Platelet activation in patients with sickle cell disease. Br J Haematol. 1998 Mar; 100(4):741-9. PMID: 9531343.
      View in: PubMed
    18. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med. 1997 May; 129(5):507-16. PMID: 9142047.
      View in: PubMed
    19. Denardo SJ, Richman CM, Goldstein DS, Shen S, Salako Q, Kukis DL, Meares CF, Yuan A, Welborn JL, Denardo GL. Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer. Anticancer Res. 1997 May-Jun; 17(3B):1735-44. PMID: 9179227.
      View in: PubMed
    20. Weick JK, Kopecky KJ, Appelbaum FR, Head DR, Kingsbury LL, Balcerzak SP, Bickers JN, Hynes HE, Welborn JL, Simon SR, Grever M. A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study. Blood. 1996 Oct 15; 88(8):2841-51. PMID: 8874180.
      View in: PubMed
    21. Beverloo HB, Le Coniat M, Wijsman J, Lillington DM, Bernard O, de Klein A, van Wering E, Welborn J, Young BD, Hagemeijer A. Breakpoint heterogeneity in t(10;11) translocation in AML-M4/M5 resulting in fusion of AF10 and MLL is resolved by fluorescent in situ hybridization analysis. Cancer Res. 1995 Oct 01; 55(19):4220-4. PMID: 7671224.
      View in: PubMed
    22. Head D, Kopecky KJ, Weick J, Files JC, Ryan D, Foucar K, Montiel M, Bickers J, Fishleder A, Miller M. Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia. Blood. 1995 Sep 01; 86(5):1717-28. PMID: 7655004.
      View in: PubMed
    23. Welborn JL, Kopecky KJ, Meyers FJ, Veith R, Shurafa M, Doroshow JH, Balcerzak SP, Appelbaum FR. Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial. Leukemia. 1995 Jul; 9(7):1126-9. PMID: 7630183.
      View in: PubMed
    24. Welborn JL. Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. Am J Hematol. 1994 Apr; 45(4):341-4. PMID: 7909983.
      View in: PubMed
    25. Welborn JL, Timm NS. Trisomy 21 and cystic hygromas in early gestational age fetuses. Am J Perinatol. 1994 Jan; 11(1):19-20. PMID: 8155202.
      View in: PubMed
    26. Welborn JL, Welborn R. Banding resolution of human chromosomes: a method of accuracy and simplicity. Am J Med Genet. 1993 Dec 01; 47(8):1180-3. PMID: 8291552.
      View in: PubMed
    27. Welborn JL, Lewis JP. Correlation of marrow iron patterns with disease status of chronic myelogenous leukemia. Leuk Lymphoma. 1993 Aug; 10(6):469-75. PMID: 8401182.
      View in: PubMed
    28. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML. HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood. 1993 Jun 15; 81(12):3197-203. PMID: 8389614.
      View in: PubMed
    29. Welborn J. 5q--in essential thrombocythemia. Cancer Genet Cytogenet. 1993 Jun; 67(2):150. PMID: 8330275.
      View in: PubMed
    30. Welborn JL, Jenks HM, Hagemeijer A. Unique clinical features and prognostic significance of the translocation (6;11) in acute leukemia. Cancer Genet Cytogenet. 1993 Feb; 65(2):125-9. PMID: 8453597.
      View in: PubMed
    31. Taylor N, Welborn JL, Lewis JP. Impact of polydonor mixed lymphocyte culture media on quantity and quality of myeloid metaphases. Cancer Genet Cytogenet. 1992 Jul 01; 61(1):46-9. PMID: 1386284.
      View in: PubMed
    32. Welborn JL, Hersch J. Blood transfusion reactions. Which are life-threatening and which are not? Postgrad Med. 1991 Dec; 90(8):125-8, 131-2, 135 passim. PMID: 1749728.
      View in: PubMed
    33. Welborn JL, O'Donnell R, Hsieh T, Eatherton J, Aspry K. Vincristine for thrombocytopenic purpura. Lancet. 1991 Feb 09; 337(8737):377-8. PMID: 1671287.
      View in: PubMed
    34. Welborn JL, Meyers FJ. A three-point approach to anemia. Postgrad Med. 1991 Feb 01; 89(2):179-83, 186. PMID: 1990391.
      View in: PubMed
    35. Welborn JL, Emrick P, Acevedo M. Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis. Am J Hematol. 1990 Sep; 35(1):18-21. PMID: 2389766.
      View in: PubMed
    36. Welborn JL, Lewis JP. Analysis of mosaic states in amniotic fluid using the in-situ colony technique. Clin Genet. 1990 Jul; 38(1):14-20. PMID: 2201467.
      View in: PubMed
    37. Meyers FJ, Welborn J, Lewis JP, Flynn N. Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses. J Clin Oncol. 1989 Feb; 7(2):173-8. PMID: 2644396.
      View in: PubMed
    38. Welborn JL, Lewis JP, Meyers FJ. Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia. Leukemia. 1988 Nov; 2(11):711-6. PMID: 3054348.
      View in: PubMed
    39. Meyers FJ, Welborn JL, Lewis JP. Improved approach to patients with normocytic anemia. Am Fam Physician. 1988 Aug; 38(2):191-5. PMID: 3407586.
      View in: PubMed
    40. Welborn J, Meyers FJ, O'Grady LF. Renal salt wasting and carboplatinum. Ann Intern Med. 1988 Apr; 108(4):640. PMID: 3279897.
      View in: PubMed
    41. Welborn JL, Lewis JP, Jenks H, Walling P. Diagnostic and prognostic significance of t(1;3)(p36;q21) in the disorders of hematopoiesis. Cancer Genet Cytogenet. 1987 Oct; 28(2):277-85. PMID: 3476187.
      View in: PubMed
    42. Lewis JP, Welborn JL, Meyers FJ, Levy NB, Roschak T. Mast cell disease followed by leukemia with clonal evolution. Leuk Res. 1987; 11(9):769-73. PMID: 3118098.
      View in: PubMed